查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771643

多體學市場規模、佔有率、趨勢分析報告（按產品與服務、類型、平台、應用、最終用途、地區、細分市場預測），2025 年至 2033 年

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

多組體學市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球多組體學市場規模預計到 2033 年將達到 98.1 億美元，2025 年至 2033 年的複合年成長率為 15.33%。

預計體學技術成本下降、私營和公共部門投資和資金籌措增加等因素將推動市場發展。此外，製藥、生物技術和學術研究機構的需求成長導致市場競爭加劇，預計也將在預測期內推動市場成長。

隨著技術的進步，體學技術的成本預計將下降，使研究人員更容易取得資料集，從而推動市場成長。各公司正專注於技術進步以降低成本。例如，亞馬遜體學服務 (AWS) 於 2022 年 11 月宣布推出 Amazon Omics Services。該服務利用生物資訊感知儲存選項來儲存原始定序數據，從而降低成本。因此，較低的成本預計將使研究人員和臨床醫生更容易獲得體學技術。這種成本降低預計將增加多體學方法的採用。

預計來自私人和公共參與者的投資和資金增加將推動對多組體學產品和服務的需求。許多公司正在大力投資多組體學平台和技術的開發。例如，2022年1月，羅氏公司向生技公司Freenome投資2.9億美元。這筆投資用於加速其用於早期癌症檢測的多組體學平台的發展。此外，2023年5月，MultiOmic Health完成了620萬美元的資金籌措，用於建立精準藥物發現平台。因此，預計資金籌措和投資的增加將推動市場上各種新型平台和產品的開發。

市場相關人員日益注重開發創新產品和服務，也是推動市場需求成長的關鍵因素。各公司正在開發新型平台，以應對日益激烈的競爭。例如，2023年2月，Via Scientific, Inc.推出了Foundry，這是一個多組體學加速器平台，支援在多組體學研究過程中自動執行複雜的數據和分析任務。預計此類產品的發布將在預測期內推動產業發展。

多組體學市場報告重點

  • 基於產品和服務部分，它將在 2024 年佔據最大的市場收益佔有率。預計該部分的成長將受到開發和產品發布數量激增的推動。
  • 根據類型，批量體學部分將在 2024 年佔據最大的市場收益佔有率。另一方面，由於對單細胞體學的需求不斷增加以了解複雜的生物系統，單細胞體學預計將以最快的速度成長，在預測期內的複合年成長率為 17.8%。
  • 基於平台，基因組學將在 2024 年佔據市場主導地位，收入佔有率為 40.63%。這一成長歸因於該領域擁有大量可用的產品。
  • 根據應用，腫瘤學領域在 2024 年佔據了最大的市場收益佔有率。預計癌症發病率的上升和多組體學在癌症中的應用的增加將推動該領域的成長。
  • 根據最終用途，預計學術和研究機構部門將在 2024 年佔據最大的市場收益佔有率。相較之下，由於對多組體學的需求不斷增加以加速藥物發現和開發，預計製藥和生物技術公司將見證最快的成長。
  • 由於該地區主要市場參與者的存在，北美在 2024 年佔據了全球市場的主導地位，收益佔有率為 48.76%。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章多組體學市場：產品與服務的商業分析

  • 細分儀表板
  • 全球體學市場：產品與服務變化分析
  • 全球多組體學市場規模與趨勢分析（產品與服務，2021-2033 年）
  • 產品
  • 服務

第5章多組體學市場：業務類型分析

  • 細分儀表板
  • 全球體學市場：類型變異分析
  • 2021 年至 2033 年全球多組體學市場規模及趨勢分析（按類型）
  • 單細胞多組體學
  • 批量體學

第6章 多組體學市場：平台業務分析

  • 細分儀表板
  • 全球體學市場平台變化分析
  • 2021 年至 2033 年全球多組體學市場規模及趨勢分析（按平台）
  • 基因組學
  • 轉錄組學
  • 蛋白質體學
  • 代謝體學
  • 整合組體學平台

7. 多體學市場：應用商業分析

  • 細分儀表板
  • 全球體學市場應用趨勢分析
  • 全球多體學市場規模和趨勢分析（按應用，2021-2033）
  • 細胞生物學
  • 腫瘤學
  • 神經病學
  • 免疫學

8. 多組體學市場：最終用途業務分析

  • 細分儀表板
  • 全球體學市場最終用途趨勢分析
  • 2021 年至 2033 年全球多組體學市場規模及趨勢分析（依最終用途）
  • 學術研究所
  • 製藥和生物技術公司
  • 其他

第9章多組體學市場：區域業務分析

  • 區域儀表板
  • 2021-2033 年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 參與企業
  • 戰略地圖
  • 2024年企業市場分析
  • 參與企業概況
    • BD
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc
    • Danaher
    • PerkinElmer Inc.
    • Shimadzu Corporation
    • Bruker
    • QIAGEN
    • Agilent Technologies, Inc.
    • BGI
Product Code: GVR-4-68040-136-5

Multiomics Market Growth & Trends:

The global multiomics market size is estimated to reach USD 9.81 billion by 2033, expanding at a CAGR of 15.33% from 2025 to 2033, according to a new report by Grand View Research, Inc. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights:

  • Based on the product segment accounted for the largest market revenue share in 2024. The segment's growth is anticipated to be driven by the development surge and the number of product launches.
  • Based on type, the bulk multiomics segment accounted for the largest market revenue share in 2024. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
  • Based on platform, genomics dominated the market with a revenue share of 40.63% in 2024. The growth is attributed to the high number of products available in this segment
  • Based on application, the oncology segment accounted for the largest market revenue share in 2024. The rising incidence of cancer and the growing use of multi-omics for cancer are anticipated to drive segment growth.
  • Based on end-use, the academic & research institutes segment accounted for the largest market revenue share in 2024. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
  • North America dominated the global industry in 2024 with a revenue share of 48. 76%, owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Type
    • 1.2.3. Platform
    • 1.2.4. Application
    • 1.2.5. End-use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Market: Product & Service Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Multiomics Market Product & Service Movement Analysis
  • 4.3. Global Multiomics Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Product
    • 4.4.1. Global Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Global Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Consumables
      • 4.4.3.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Software
      • 4.4.4.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Global Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Multiomics Market: Type Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Multiomics Market Type Movement Analysis
  • 5.3. Global Multiomics Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4. Single-cell Multiomics
    • 5.4.1. Global Single-cell Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Bulk Multiomics
    • 5.5.1. Global Bulk Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Multiomics Market: Platform Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Multiomics Market Platform Movement Analysis
  • 6.3. Global Multiomics Market Size & Trend Analysis, by Platform, 2021 to 2033 (USD Million)
  • 6.4. Genomics
    • 6.4.1. Global Genomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Transcriptomics
    • 6.5.1. Global Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Proteomics
    • 6.6.1. Global Proteomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Metabolomics
    • 6.7.1. Global Metabolomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Integrated Omics Platforms
    • 6.8.1. Global Integrated Omics Platforms Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Multiomics Market: Application Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Multiomics Market Application Movement Analysis
  • 7.3. Global Multiomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 7.4. Cell Biology
    • 7.4.1. Global Cell Biology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Global Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Neurology
    • 7.6.1. Global Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Immunology
    • 7.7.1. Global Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Multiomics Market: End-use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Multiomics Market End-use Movement Analysis
  • 8.3. Global Multiomics Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
  • 8.4. Academic and Research Institutes
    • 8.4.1. Global Academic and Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Pharmaceutical & Biotechnology Companies
    • 8.5.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 9.3. North America
    • 9.3.1. North America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Australia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Thailand Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. South Korea Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Participant's Overview
    • 10.4.1. BD
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Thermo Fisher Scientific Inc.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Illumina, Inc
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Danaher
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. PerkinElmer Inc.
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Shimadzu Corporation
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Bruker
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. QIAGEN
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Agilent Technologies, Inc.
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. BGI
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 4 Global multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 5 Global multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 6 Global multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 7 Global multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 8 Global multiomics market, by region, 2021 - 2033 (USD Million)
  • Table 9 North America multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 10 North America multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 11 North America multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 12 North America multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 13 North America multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 14 North America multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 15 U.S. multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 16 U.S. multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 17 U.S. multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 18 U.S. multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 19 U.S. multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 20 Canada multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 21 Canada multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 22 Canada multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 23 Canada multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 24 Canada multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 25 Mexico multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 26 Mexico multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 27 Mexico multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 28 Mexico multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 29 Mexico multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 30 Europe multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 31 Europe multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 32 Europe multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 33 Europe multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 34 Europe multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 35 Europe multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 36 UK multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 37 UK multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 38 UK multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 39 UK multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 40 UK multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 41 Germany multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 42 Germany multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 43 Germany multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 44 Germany multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 45 Germany multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 46 France multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 47 France multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 48 France multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 49 France multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 50 France multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 51 Italy multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 52 Italy multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 53 Italy multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 54 Italy multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 55 Italy multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 56 Spain multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 57 Spain multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 58 Spain multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 59 Spain multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 60 Spain multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 61 Denmark multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 62 Denmark multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 63 Denmark multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 64 Denmark multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 65 Denmark multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 66 Sweden multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 67 Sweden multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 68 Sweden multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 69 Sweden multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 70 Sweden multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 71 Norway multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 72 Norway multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 73 Norway multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 74 Norway multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 75 Norway multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 82 Japan multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 83 Japan multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 84 Japan multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 85 Japan multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 86 Japan multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 87 China multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 88 China multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 89 China multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 90 China multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 91 China multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 92 India multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 93 India multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 94 India multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 95 India multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 96 India multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 97 Australia multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 98 Australia multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 99 Australia multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 100 Australia multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 101 Australia multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 102 Thailand multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 103 Thailand multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 104 Thailand multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 105 Thailand multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 106 Thailand multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 107 South Korea multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 108 South Korea multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 109 South Korea multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 110 South Korea multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 111 South Korea multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 112 Latin America multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 113 Latin America multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 114 Latin America multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 115 Latin America multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 116 Latin America multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 117 Latin America multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 118 Brazil multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 119 Brazil multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 120 Brazil multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 121 Brazil multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 122 Brazil multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 123 Argentina multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 124 Argentina multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 125 Argentina multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 126 Argentina multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 127 Argentina multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 128 Middle East & Africa multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 129 Middle East & Africa multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 130 Middle East & Africa multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 131 Middle East & Africa multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 132 Middle East & Africa multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 133 Middle East & Africa multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 134 South Africa multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 135 South Africa multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 136 South Africa multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 137 South Africa multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 138 South Africa multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 143 Saudi Arabia multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 144 UAE multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 145 UAE multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 146 UAE multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 147 UAE multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 148 UAE multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 149 Kuwait multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 150 Kuwait multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 151 Kuwait multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 152 Kuwait multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 153 Kuwait multiomics market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Multiomics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Multiomics market driver analysis
  • Fig. 12 Multiomics market restraint analysis
  • Fig. 13 Multiomics market: Porter's analysis
  • Fig. 14 Multiomics market: PESTEL analysis
  • Fig. 15 Multiomics market: Product & service outlook and key takeaways
  • Fig. 16 Multiomics market: Product & service market share analysis, 2024 - 2033
  • Fig. 17 Global multiomics by products market, 2021 - 2033 (USD Million)
  • Fig. 18 Global multiomics by instruments market, 2021 - 2033 (USD Million)
  • Fig. 19 Global multiomics by consumables market, 2021 - 2033 (USD Million)
  • Fig. 20 Global multiomics by software market, 2021 - 2033 (USD Million)
  • Fig. 21 Global multiomics by services market, 2021 - 2033 (USD Million)
  • Fig. 22 Multiomics market: Type outlook and key takeaways
  • Fig. 23 Multiomics market: Type market share analysis, 2024 - 2033
  • Fig. 24 Global single-cell multiomics by men market, 2021 - 2033 (USD Million)
  • Fig. 25 Global multiomics by bulk multiomics market, 2021 - 2033 (USD Million)
  • Fig. 26 Multiomics market: Platform outlook and key takeaways
  • Fig. 27 Multiomics market: Platform market share analysis, 2024 - 2033
  • Fig. 28 Global multiomics by genomics market, 2021 - 2033 (USD Million)
  • Fig. 29 Global multiomics by transcriptomics market, 2021 - 2033 (USD Million)
  • Fig. 30 Global multiomics by proteomics market, 2021 - 2033 (USD Million)
  • Fig. 31 Global multiomics by metabolomics market, 2021 - 2033 (USD Million)
  • Fig. 32 Global multiomics by integrated omics platforms market, 2021 - 2033 (USD Million)
  • Fig. 33 Multiomics market: Application outlook and key takeaways
  • Fig. 34 Multiomics market: Application market share analysis, 2024 - 2033
  • Fig. 35 Global multiomics by cell biology market, 2021 - 2033 (USD Million)
  • Fig. 36 Global multiomics by oncology market, 2021 - 2033 (USD Million)
  • Fig. 37 Global multiomics by neurology market, 2021 - 2033 (USD Million)
  • Fig. 38 Global multiomics by immunology market, 2021 - 2033 (USD Million)
  • Fig. 39 Multiomics market: End-use outlook and key takeaways
  • Fig. 40 Multiomics market: End-use market share analysis, 2024 - 2033
  • Fig. 41 Global multiomics by academic and research institutes market, 2021 - 2033 (USD Million)
  • Fig. 42 Global multiomics by pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 43 Global multiomics by others market, 2021 - 2033 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. key country dynamics
  • Fig. 47 U.S. multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Canada key country dynamics
  • Fig. 49 Canada multiomics market, 2021 - 2033 (USD Million)
  • Fig. 50 Europe multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 UK key country dynamics
  • Fig. 52 UK multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Germany key country dynamics
  • Fig. 54 Germany multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 France key country dynamics
  • Fig. 56 France multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Italy key country dynamics
  • Fig. 58 Italy multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Spain key country dynamics
  • Fig. 60 Spain multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Denmark key country dynamics
  • Fig. 62 Denmark multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Sweden key country dynamics
  • Fig. 64 Sweden multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Norway key country dynamics
  • Fig. 66 Norway multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Asia-Pacific multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 China key country dynamics
  • Fig. 71 China multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 India key country dynamics
  • Fig. 73 India multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Australia key country dynamics
  • Fig. 75 Australia multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 76 Thailand key country dynamics
  • Fig. 77 Thailand multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 78 South Korea key country dynamics
  • Fig. 79 South Korea multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 Latin America multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 81 Brazil key country dynamics
  • Fig. 82 Brazil multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 83 Mexico key country dynamics
  • Fig. 84 Mexico multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 85 Argentina key country dynamics
  • Fig. 86 Argentina multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 87 MEA multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 88 South Africa key country dynamics
  • Fig. 89 South Africa multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 90 Saudi Arabia key country dynamics
  • Fig. 91 Saudi Arabia multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 92 UAE key country dynamics
  • Fig. 93 UAE multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 94 Kuwait key country dynamics
  • Fig. 95 Kuwait multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 96 Key company categorization
  • Fig. 97 Company market positioning
  • Fig. 98 Market participant categorization
  • Fig. 99 Strategy framework